With no efficacy data available, is the Bharat Biotech vaccine against the coronavirus safe and effective? The Serum Institute of India vaccine will be the main drug, AIIMS Director Dr Randeep Guleria told NDTV, adding that the Bharat Biotech vaccine will only be used as a backup. | NDTV
22:13
With no efficacy data available, is the Bharat Biotech vaccine against the coronavirus safe and effective? The Serum Institute of India vaccine will be the main drug, AIIMS Director Dr Randeep Guleria told NDTV, adding that the Bharat Biotech vaccine will only be used as a backup. | NDTV
50.3K viewsJan 2, 2021
FacebookNDTV
Bharat Biotech | LinkedIn
Bharat Biotech | LinkedIn
Mar 11, 2019
linkedin.com
‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results
2:31
‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results
Mar 3, 2021
Hindustan TimesMohammad Shuaib
"Don't Accuse Us Of Inexperience, We Are Global Company": Bharat Biotech |
41:21
"Don't Accuse Us Of Inexperience, We Are Global Company": Bharat Biotech |
Jan 4, 2021
NDTV
Bharat Biotech's Vaccine Cleared By Expert Panel
5:46
Bharat Biotech's Vaccine Cleared By Expert Panel
Jan 2, 2021
NDTVSonal Mehrotra
Bharat Biotech to meet WHO to get EUL approval
2:34
Bharat Biotech to meet WHO to get EUL approval
Jun 23, 2021
timesnownews.comTamanna Inamdar
Hyderabad-based Bharat Biotech is working on developing what could be a nasal vaccine to fight the coronavirus pandemic. This vaccine, when ready, will be delivered intranasally. NDTV's Uma Sudhir spoke with Bharat Biotech Joint Managing Director Suchitra Ella. | NDTV
7:04
Hyderabad-based Bharat Biotech is working on developing what could be a nasal vaccine to fight the coronavirus pandemic. This vaccine, when ready, will be delivered intranasally. NDTV's Uma Sudhir spoke with Bharat Biotech Joint Managing Director Suchitra Ella. | NDTV
46.1K viewsApr 28, 2020
FacebookNDTV
2:28
Bharat Biotech announces interim analysis results of Phase3 trials Track latest news updates https://bit.ly/2Qo1kkm | The Economic Times
14.7K viewsApr 21, 2021
FacebookThe Economic Times
‘I’m from farmer family...’: Vaccine-maker Bharat Biotech’s MD on controversy
Jan 4, 2021
Hindustan TimesHT Correspondent
0:55
The company that gave the world "Covaxin" in the fight against COVID, Bharat Biotech, and its employees, who worked relentlessly, are now having a well-deserved gala time with their families at Ramoji Film City. Bharat Biotech #ramojifilmcity #Covaxin #BharatBiotech | Ramoji Film City
1.5K viewsJan 10, 2023
FacebookRamoji Film City
1:03
Bharat Biotech plans to launch its Covid-19 vaccine in Q2 of next year. The release is contingent on whether it gets the requisite approvals from the Indian regulatory authorities. Its immediate focus is to conduct the Phase 3 trials successfully across sites in the country. Covaxin-the company's vaccine candidate- has been developed in collaboration with the ICMR and National Institute of Virology. They used inactivated Sars-Cov-2, the virus that causes Covid-19. The virus was isolated in an IC
24.7K viewsNov 1, 2020
FacebookThe Times of India
2:53
A letter by the ICMR asked the company to launch Covaxin by August 15. Bharat Biotech has been asked to accelerate its trails as well and to adhere to the timelines. even DCGI has cleared 'Covaxin' trails. | News18
10.4K viewsJul 4, 2020
FacebookNews18
Bharat Biotech applies for WHO approval, pre-submission meeting soon
May 24, 2021
india.com
1:57
Bharat Biotech Says Phase 3 Results Public By July
Jun 9, 2021
NDTVVishnu Som
7:36
Bharat Biotech has released the final phase 3 efficacy data. The company claims it's made in India vaccine, Covaxin, has shown overall efficacy of 77.8%. The data, however, is yet to be peer-reviewed. | NDTV
9.4K viewsJul 3, 2021
FacebookNDTV
10:26
Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
Jul 3, 2021
NDTV
Bharat Biotech's Covid Nasal Vaccine Gets Regulator's Nod For Holding Phase 2, 3 Clinical Trials
Aug 13, 2021
abplive.com
Inactivated vaccines safest with lesser adverse reactions: Bharat Biotech
Dec 21, 2020
INDIA TV
India's Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028
10 months ago
bluewaterhealthyliving.com
Bharat Biotech to ramp up Covaxin production to additional 200 million doses per year
May 20, 2021
india.com
0:47
Bharat Biotech plans to launch coronavirus vaccine Covaxin
Nov 2, 2020
India TodayIndia Today Television
Bharat Biotech releases risks, benefits of Covaxin, asks pregnant women to avoid dose
Jan 19, 2021
India TodayIndia Today Web Desk
Bharat Biotech seeks nod for intranasal Covid-19 vaccine as booster Dose
Dec 20, 2021
India TodayIndia Today Television
Covaxin phase 4 trials to be conducted soon, phase 3 data to be out in July: Bharat Biotech
Jun 9, 2021
india.com
Covaxin: Bharat Biotech's corona vaccine will be 60% effective, says top official
Nov 22, 2020
India TodayIndia Today Television
20:18
Vaccine will definitely be there by end of this year: Bharat Biotech MD on Covaxin
Jul 1, 2020
India TodayIndia Today Television
1:00
Covaxin, the Covid-19 vaccine, being developed by Bharat Biotech is now undergoing phase-3 trials. The company is also working on another vaccine for Covid-19. The new vaccine would be in the form of nasal drops and can be ready by next year. Bharat Biotech is the only vaccine company in the world which has BSL3 production facility. Covaxin is being developed by Bharat Biotech, in collaboration with ICMR and National Institute of Virology. | The Times of India
29.4K viewsNov 16, 2020
FacebookThe Times of India
1:50
SEC holds meeting to review Bharat Biotech's Intranasal Covid-19 Vaccine; first to be 'eco-friendly'
Jan 19, 2021
timesnownews.com
Bharat Biotech's Covaxin shows 77.8 % efficacy against COVID: Lancet study
Nov 12, 2021
india.com
List of Top 10 Indian Biotech and Pharma Companies Developing COVID-19 Vaccines - The Indian Wire
May 29, 2020
theindianwire.com
See more